Cargando…
Relationship Between Metformin Use and Recurrence and Survival in Patients With Resected Stage III Colon Cancer Receiving Adjuvant Chemotherapy: Results From North Central Cancer Treatment Group N0147 (Alliance)
BACKGROUND. Preclinical and epidemiological data suggest that metformin might have antineoplastic properties against colon cancer (CC). However, the effect of metformin use on patient survival in stage III CC after curative resection is unknown. The survival outcomes were comparable regardless of th...
Autores principales: | Singh, Preet Paul, Shi, Qian, Foster, Nathan R., Grothey, Axel, Nair, Suresh G., Chan, Emily, Shields, Anthony F., Goldberg, Richard M., Gill, Sharlene, Kahlenberg, Morton S., Sinicrope, Frank A., Sargent, Daniel J., Alberts, Steven R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AlphaMed Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153338/ https://www.ncbi.nlm.nih.gov/pubmed/27881709 http://dx.doi.org/10.1634/theoncologist.2016-0153 |
Ejemplares similares
-
Prognosis of microsatellite instability and/or mismatch repair deficiency stage III colon cancer patients after disease recurrence following adjuvant treatment: results of an ACCENT pooled analysis of seven studies
por: Taieb, J., et al.
Publicado: (2019) -
Contribution of Immunoscore and Molecular Features to Survival Prediction in Stage III Colon Cancer
por: Sinicrope, Frank A, et al.
Publicado: (2020) -
The consensus Immunoscore in phase 3 clinical trial (N0147) and impact on patient management decisions
por: Lanzi, Anastasia, et al.
Publicado: (2020) -
A Study of Thymidylate Synthase Expression as a Biomarker for Resectable Colon Cancer: Alliance (Cancer and Leukemia Group B) 9581 and 89803
por: Niedzwiecki, Donna, et al.
Publicado: (2016) -
Association of Adiponectin and Vitamin D With Tumor Infiltrating Lymphocytes and Survival in Stage III Colon Cancer
por: Sinicrope, Frank A, et al.
Publicado: (2021)